SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Spitz who wrote (889)5/25/2001 2:34:42 PM
From: Starlight  Read Replies (1) of 1154
 
Total cash decreased because of purchase of Marketable Securities (which increased by about $27K over the prior report):

RE: Corporate Filings show the following:

Total cash and equivalents decreased from over 52 million to less than 22 million in the preceding 12 month period


(Check the financials at the company's website:)

ccbn.secinfo.com.

At August 31, 2000 and February 24, 2001, the Company's cash, cash equivalents
and marketable securities consisted of the following:

· Download Table

August 31, February 24,
2000 2001
---- ----

Cash and Cash Equivalents:
Cash .................................. $42,211,172 $21,115,572
Debt securities ....................... 9,900,000 501,032
----------- -----------
Total cash and cash equivalents $52,111,172 $21,616,604
=========== ===========
Marketable Securities:
Short-term securities ................. $22,348,841 $40,422,234
----------- -----------
Long-term securities .................. 1,224,184 9,584,205
=========== ===========
Total marketable securities ... $23,573,025 $50,006,439
=========== ===========

The Company has $200,000 in restricted cash in connection with certain long-term
obligations (see Note 8).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext